Medicaid expansion and drug overdose mortality during the COVID-19 pandemic in the United States

Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic

(2021) Alyssa M Peckham et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder

(2021) Corey S. Davis et al.   ANNALS OF EMERGENCY MEDICINE

Changes in US Medicaid Enrollment During the COVID-19 Pandemic

(2021) Peggah Khorrami et al.   JAMA Network Open

Supervised Injection Facilities as Harm Reduction: A Systematic Review

(2021) Timothy W. Levengood et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Association between state Medicaid expansion status and naloxone prescription dispensing

(2020) Minji Sohn et al.   HEALTH SERVICES RESEARCH

An overdose surge will compound the COVID-19 pandemic if urgent action is not taken

(2020) Sarah E. Wakeman et al.   NATURE MEDICINE

Best Practices for A Novel EMS-Based Naloxone Leave Behind Program

(2020) Becca M. Scharf et al.   Prehospital Emergency Care

Early Medicaid Expansions and Drug Overdose Mortality in the USA: a Quasi-experimental Analysis

(2018) Atheendar S. Venkataramani et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

State legal innovations to encourage naloxone dispensing

(2017) Corey Davis et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment

(2017) Hefei Wen et al.   MEDICAL CARE

Primary care models for treating opioid use disorders: What actually works? A systematic review

(2017) Pooja Lagisetty et al.   PLoS One

Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies

(2009) Enrique F. Schisterman et al.   EPIDEMIOLOGY